Have you adopted vemurafenib in BRAF+ mutated metastatic CRC? - 101341

Spotlight
Video

Have you adopted vemurafenib in BRAF+ mutated metastatic CRC?

obr has 300 videos Subscribe Here

Loading........
Description: Jeffrey Meyehardt, MD of Harvard Medical School discusses the use of vemurafenib in BRAF+ mutated metastatic colorectal cancer at the 2017 ASCO Annual Meeting in Chicago, IL.
Shared By : obr
Posted on : 06/21/17
Added : 1 year ago
Category : Colorectal Cancer